Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Anemia, Refractory, with Excess of Blasts 41Myelodysplastic Syndromes 37Leukemia 36Precursor Cell Lymphoblastic Leukemia-Lymphoma 32Leukemia, Myeloid, Acute 31Leukemia, Myelomonocytic, Chronic 28Leukemia, Myeloid, Chronic-Phase 27Leukemia, Lymphocytic, Chronic, B-Cell 25Anemia, Refractory 25Lymphoma, Non-Hodgkin 23Lymphoma, Mantle-Cell 22Leukemia, Myeloid, Accelerated Phase 22Multiple Myeloma 21Lymphoma, Follicular 21Myeloproliferative Disorders 20Congenital Abnormalities 20Burkitt Lymphoma 20Lymphoma, Large B-Cell, Diffuse 19Lymphoma, B-Cell, Marginal Zone 19Lymphoma 19Lymphoma, Large-Cell, Immunoblastic 18Hodgkin Disease 17Primary Myelofibrosis 16Blast Crisis 16Dendritic Cell Sarcoma, Interdigitating 14Neoplasms, Plasma Cell 11Myelodysplastic-Myeloproliferative Diseases 11Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 11Graft vs Host Disease 11Recurrence 9

Interventions

thymoglobulin 1Mycophenolic Acid 1Cyclosporine 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neural Tube Defects × Cyclosporine × Classical hematology × Clear all
NCT01392989 2019-05-07

Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders

Stanford University

Phase 2 Completed
44 enrolled 13 charts
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Leukemia, Myeloid, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neural Tube Defects

Data powered by HemOnc (CC BY 4.0) Colophon âš¡